Events

img

Pharmacology and Toxicology of the Blood-Brain Barrier: State of the Art, Needs for Future Research and Expected Benefits for the EU

Conference

Start Time: 11 Feb 2010

End Time: 12 Feb 2010

Where: Brussels, Brussels, Belgium

ABSTRACTS

Displaying 1 - 25 out of 29 Abstracts

Conference Abstract, Published on 22 Feb 2010

Introduction

Alan R Boobis

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00001

Conference Abstract, Published on 22 Feb 2010

Structure and function of the blood-brain barrier

N. Joan Abbott and Siti R Yusof

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00002

Conference Abstract, Published on 23 Feb 2010

Role of the blood-brain barrier in disposition of endobiotics and xenobiotics

Olavi Pelkonen

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00005

Conference Abstract, Published on 23 Feb 2010

Glucose sensing and uptake in the brain

Shlomo Sasson

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00006

Conference Abstract, Published on 23 Feb 2010

Regulation of Immune Cell Entry into the Central Nervous System

Britta Engelhardt

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00008

Conference Abstract, Published on 23 Feb 2010

Bile acid derivatives as blood-brain barrier modifiers

Momir Mikov, Vasovic V, Golocorbin-kon S, Kuhajda K, Kevresan S and Jakovljevic V

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00009

Conference Abstract, Published on 24 Feb 2010

Improvement of central nervous system pharmacotherapy by modulation of Pglycoprotein at the blood-brain barrier

David S Miller

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00010

Conference Abstract, Published on 25 Feb 2010

The blood-brain barrier in toxicology

Ursula Gundert-Remy and Ralf Stahlmann

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00011

Conference Abstract, Published on 25 Feb 2010

4-Hydroxynoneal as second messenger of free radicals in the blood-brain barrier

Kamelija Zarkovic, Marina Cindric, Danijela Kolenc and Neven Zarkovic

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00012

Conference Abstract, Published on 25 Feb 2010

Drug/natural product interactions at the blood brain barrier

Gert Fricker, Melanie Ott and Valeska Reichel

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00013

Conference Abstract, Published on 01 Mar 2010

Methods for estimation of brain active site concentration of drugs and other chemicals

Margareta Hammarlund-Udenaes

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00014

Conference Abstract, Published on 10 Mar 2010

The Blood Brain Barrier: a Critical Interface in Neuroinflammation and Route to Therapeutic Intervention

Trevor Owens, Jessica L Teeling and V. Hugh Perry

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00016

Conference Abstract, Published on 10 Mar 2010

AN EXPERIMENTAL MODEL FOR THE ALZHEIMER PHENOTYPE OF COGNITIVE DEFICITS

Ryszard Pluta, Anna Kiryk, Marzena Ułamek, Leszek Kaczmarek and Mirosław Jabłoński

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00018

Conference Abstract, Published on 10 Mar 2010

COST Chemistry Action D34 ‘Molecular Targeting and Drug Design in Neurological and Bacterial Diseases'

Robert R Crichton

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00019

Conference Abstract, Published on 10 Mar 2010

COST BM0602 - Adipose Tissue: A Key Target for Prevention of the Metabolic Syndrome

Juergen Eckel

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00020

Conference Abstract, Published on 12 Mar 2010

An in vitro model of the Blood Brain Barrier (BBB)

David T Dexter

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00021

Conference Abstract, Published on 11 Mar 2010

Cell microencapsulation technology for drug delivery in the CNS

Gorka Orive, Rosa M Hernández and José Luis Pedraz

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00022

Conference Abstract, Published on 11 Mar 2010

Imaging the Breakdown of the BBB and Neuroinflammation in Models of
Neurodegeneration

Pavle R Andjus, Fabrizio Michetti, Ryszard Pluta and Goran Bačić

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00023

Conference Abstract, Published on 11 Mar 2010

Use of nanoparticles to deliver therapeutics to the CNS

Jörg Kreuter

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00024

Conference Abstract, Published on 11 Mar 2010

Receptor-mediated delivery of drugs across the blood-brain barrier

Jaap Rip, Chantal C.M Appeldoorn, Francesca M Manca, Rick Dorland, Joan M.R Van Kregten and Pieter J Gaillard

Front. Pharmacol.  doi: 10.3389/conf.fphar.2010.02.00025

Displaying 1 - 25 out of 29 Abstracts

You are in

Pharmacology

RSVP